Stockreport

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF - Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced - Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengt [Read more]